XML 36 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity
6 Months Ended
Jun. 30, 2012
Equity [Abstract]  
Equity
10. 
Equity
         
Stock Incentive Plans
 
The Company has three share-based compensation plans: the MiMedx Group, Inc. Assumed 2006 Stock Incentive Plan (the "2006 Plan"), the MiMedx Inc. 2007 Assumed Stock Plan (the "Assumed 2007 Plan") and the MiMedx Group Inc. Amended and Restated Assumed 2005 Stock Plan (the "Assumed 2005 Plan") which provide for the granting of qualified incentive and non-qualified stock options, stock appreciation awards and restricted stock awards to employees, directors, consultants and advisors. The awards are subject to a vesting schedule as set forth in each individual agreement. The Company intends to use only the 2006 Plan to make future grants. The number of assumed options under the Assumed 2005 Plan and Assumed 2007 Plan outstanding at June 30, 2012 totaled 375,000.  On May 10, 2012, the Board of Directors approved 4,000,000 additional shares to be made available under the 2006 Plan, bringing the maximum number of shares of common stock which can be issued under the 2006 Plan to 16,500,000 at June 30, 2012.
 
Activity with respect to the stock options is summarized as follows:
 
   
Number of
Shares
  
Weighted-
Average
Exercise
Price
  
Weighted-
Average
Remaining
Contractual
Term
(in years)
  
Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2012
  10,333,583  $1.17       
Granted
  2,948,000  $1.26       
Exercised
  (324,750) $0.98       
Forfeited or cancelled/expired
  (162,583) $1.11       
Outstanding at June 30, 2012
  12,794,250  $1.20   7.3  $11,728,020 
                  
Vested or expected to vest at June 30, 2012
  7,106,810  $1.17   5.9  $6,763,936 
 
The intrinsic value of the options exercised during the three months ended June 30, 2012, was approximately $83,000.
 
Following is a summary of stock options outstanding and exercisable at June 30, 2012:

   
Options Outstanding
  
Options Exercisable
 
Range of Exercise Prices
  
Number
outstanding
  
Weighted-
Average
Remaining
Contractual
Term
(in years)
  
Weighted-
Average
Exercise Price
  
Number
Exercisable
  
Weighted-
Average
Exercise Price
 
$0.50   566,250   2.4  $0.50   554,223  $0.50 
$0.65 - $1.00   2,717,500   5.6  $0.78   2,624,179  $0.78 
$1.04 - $1.80   8,960,500   8.7  $1.29   3,378,408  $1.39 
$2.40   550,000   0.2  $2.40   550,000  $2.40 
     12,794,250   7.3  $1.20   7,106,810  $1.17 
 
A summary of the status of the Company's unvested stock options follows:
 
   
Number of
Shares
  
Weighted-
Average
Grant Date Fair Value
 
Unvested at January 1, 2012
  4,333,086  $0.72 
Granted
  2,948,000  $0.67 
Cancelled/expired
  (162,583) $0.68 
Vested
  (1,431,063) $0.74 
Unvested at June 30, 2012
  5,687,440  $0.69 
 
Total unrecognized compensation expense related to granted stock options at June 30, 2012, was approximately $4,120,000 and will be charged to expense through July 2015.
 
The fair value of options granted by the Company is estimated on the date of grant using the Black-Scholes-Merton option-pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate.  Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the options.  The term of employee options granted is derived using the "simplified method" which computes expected term as the average of the sum of the vesting term plus the contract term.  The term for non-employee options is generally based upon the contractual term of the option.  The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term or contractual term as described.
 
The assumptions used in calculating the fair value of options using the Black-Scholes-Merton option-pricing model are set forth in the following table:

   
Six months ended June 30,
 
   
2012
  
2011
 
Expected volatility
  58.31 - 59.04%  57.3 - 57.6%
Expected life (in years)
  6   6 
Expected dividend yield
  -   - 
Risk-free interest rate
  0.62% - 1.22%  1.48% - 2.24%
 
The weighted-average grant date fair value for options granted during the six months ended June 30, 2012 was approximately $0.67.
 
Warrants
 
The Company grants common stock warrants in connection with equity share purchases by investors as an additional incentive for providing long term equity capital to the Company and as additional compensation to consultants and advisors.  The warrants are granted at negotiated prices in connection with the equity share purchases and at the market price of the common stock in other instances.  The warrants have been issued for terms of five years.
 
Following is a summary of warrants outstanding at June 30, 2012:

   
Number of
Warrants
  
Weighted-
Average
Exercise
 Price per
Warrant
  
Number of
Contingent
Warrants
  
Weighted-
Average
Exercise
Price per
Contingent
Warrant
 
Warrants outstanding at January 1, 2012
  9,388,817  $1.00   5,245,484  $0.01 
Issued in connection with private placement of common stock
  1,672,743  $0.01   (1,672,743) $0.01 
Issued in connection with line of credit with related party
  325,000  $0.01   (325,000) $0.01 
Warrants exercised
  (3,621,052) $0.09   -   - 
Warrants redeemed for cashless exercises
  (1,691) $0.09   -   - 
Warrants outstanding at June 30, 2012
  7,763,817  $1.17   3,247,741  $0.01 
 
Warrants may be exercised in whole or in part by:
 
·
notice given by the holder accompanied by payment of an amount equal to the warrant exercise price multiplied by the number of warrant shares being purchased; or
 
·
election by the holder to exchange the warrant (or portion thereof) for that number of shares equal to the product of (a) the number of shares issuable upon exercise of the warrant (or portion) and (b) a fraction, (x) the numerator of which is the market price of the shares at the time of exercise minus the warrant exercise price per share at the time of exercise and (y) the denominator of which is the market price per share at the time of exercise.
 
These warrants are not mandatorily redeemable, do not obligate the Company to repurchase its equity shares by transferring assets or issue a variable number of shares.
 
The warrants require that the Company deliver shares as part of a physical settlement or a net-share settlement, at the option of the holder, and do not provide for a net-cash settlement.
 
All of our warrants are classified as equity as of June 30, 2012 and December 31, 2011.